首页> 外文期刊>Nature Materials >Complete prevention of blood loss with self-sealing haemostatic needles
【24h】

Complete prevention of blood loss with self-sealing haemostatic needles

机译:自封止血针完全预防失血

获取原文
获取原文并翻译 | 示例

摘要

Bleeding is largely unavoidable following syringe needle puncture of biological tissues and, while inconvenient, this typically causes little or no harm in healthy individuals. However, there are certain circumstances where syringe injections can have more significant side effects, such as uncontrolled bleeding in those with haemophilia, coagulopathy, or the transmission of infectious diseases through contaminated blood. Herein, we present a haemostatic hypodermic needle able to prevent bleeding following tissue puncture. The surface of the needle is coated with partially crosslinked catechol-functionalized chitosan that undergoes a solid-to-gel phase transition in situ to seal punctured tissues. Testing the capabilities of these haemostatic needles, we report complete prevention of blood loss following intravenous and intramuscular injections in animal models, and 100% survival in haemophiliac mice following syringe puncture of the jugular vein. Such self-sealing haemostatic needles and adhesive coatings may therefore help to prevent complications associated with bleeding in more clinical settings.
机译:注射器针头刺穿生物组织后,在很大程度上流血是不可避免的,尽管不便,但通常对健康个体几乎没有伤害。但是,在某些情况下,注射器注射会产生更大的副作用,例如血友病患者的失血,凝血病或通过污染的血液传播传染病。本文中,我们介绍了一种止血皮下注射针,能够防止组织穿刺后出血。针的表面涂有部分交联的邻苯二酚官能化的壳聚糖,该壳聚糖在原位经历了固-凝胶相变,以密封穿刺的组织。测试这些止血针的功能后,我们报告了在动物模型中静脉内和肌肉内注射后完全预防失血的情况,以及在针刺颈静脉的血友病小鼠中100%的存活率。因此,这种自密封止血针和粘合剂涂层可以在更多的临床环境中帮助防止与出血相关的并发症。

著录项

  • 来源
    《Nature Materials》 |2017年第1期|147-152|共6页
  • 作者单位

    The Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.;

    Predictive Model Research Center, Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea.;

    Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.;

    R&D Center, InnoTherapy Inc., Seoul 07327, Republic of Korea.;

    R&D Center, InnoTherapy Inc., Seoul 07327, Republic of Korea.;

    R&D Center, InnoTherapy Inc., Seoul 07327, Republic of Korea.;

    Meta-Biomed Co., Cheongju, Chungbuk 28161, Republic of Korea,;

    Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.;

    Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.;

    Predictive Model Research Center, Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea.,Department of Human and Environmental Toxicology, University of Science and Technology, Daejeon 34113, Republic of Korea.;

    Predictive Model Research Center, Korea Institute of Toxicology (KIT), Daejeon 34114, Republic of Korea.,Department of Human and Environmental Toxicology, University of Science and Technology, Daejeon 34113, Republic of Korea.,These authors contributed equally to this work.;

    The Graduate School of Nanoscience and Technology, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.,Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.,R&D Center, InnoTherapy Inc., Seoul 07327, Republic of Korea.,These authors contributed equally to this work.;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号